FDA Investigator Angela Shepas

Angela Shepas has conducted inspections on 177 sites in 14 countries as of 28 Jul 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
177
Last Inspection Date:
28 Jul 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Brazil, Italy, Switzerland, Netherlands, France, Ukraine, Romania, United Kingdom of Great Britain and Northern Ireland, Belgium, Spain, India, Portugal, Greece
FDA Investigators that have inspected at least one site in common with Angela Shepas:
Ademola O Daramola, Albert Rodriguez, Alejandra Mcclellan, Alexandra B Pitkin, Alexandria L Capuano, Allen F Hall, Althea A Williams, Amalia C Himaya, Amir Alavi, Ana Djurdjevic, Anderson, Andrace L Deyampert, Andrea A Branche, Andy B Lee, Angelica G Aziz, Anthony E Keller, RPh, Anya Dlockett Evans, April P Shaw, Arie C Menachem, Armando Chavez, MS, Arsen Karapetyan, Barbara D Wright, Barbara J Rincon, Bichsa T Tran, Binh T Nguyen, Bonnie I Needleman, Brenda K Alford, Brian E Thompson, Brian P Putz, Brian Ravitch, Bryan A Galvez, Burnsb, Bush, Carey A Watson, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Cathryn M Groehnert, Celena Ngo, Charles L Larson, Cheron M Portee, Cheryl D Mccall, Christina D Mello, Christina N Maurino, Christopher D Washington, Christopher Do, Christopher M Jenner, Colleen E Burke, Comyar Shoghi, Corey A Cruse, Creighton T Tuzon, Daniel W Cline, Darren S Brown, Darrin E Davis, David G Whitman, David Serrano, David Y Hernandez, Davis, Debbie K Giang, Deborah A Greco, Deborah W Hsu, Debra D Devlieger, Debra J Fracassa, Deidre R Edwards, Dejon N Harris, Desiree C Iya, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Dolores Harper, Donna Ltartaglino Besone, Dr. Mark J Seaton, PhD, Durell L Giles, Dyana K Stone, Eileen T Dupont, Elizabeth A Dakan, Ellen N Stewart, Emmanuel B Diric, Erik D Sandvig, Fe Q Reyes, Finn A Slizza, Francisco, Gabriel Craig, Garciam, Gene D Arcy, Gene R Gunn, Geoffrey M Leist, Geraldine M Peregrin, Grace P Santos, Greg K Keshishyan, Habacuc V Barrera, Hagstrom, Henry E Carrillo, Herminio C Francisco, Himanshu Gupta, PhD, Humberto Z Gomez, Iris C Macinnes, Irma D Padilla, Jacob W Reynolds, Jacqueline O Snell, James A Barreto, James D Hildreth, James P Stallings, James P Stumpff, James R Fleckenstein, Janet Pulver, Janice K Pohlman, MD, MPH, Jasmine Y Wang, Jazmine M Welcher, Jeff M Uriarte, Jeffrey P Raimondi, Jennifer M Gogley, Jenny L Chisem, Jessica L Andrade, Jhakeim D Seaberry, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Daubenspeck, John C Sedwick, John L Stevens, John R Myung, Jonathan K Dare, Jorge M Ruano Rossil, Jose A Torres, Joseph C Francisco, Joseph C Yen, Joseph H Lam, Joshua J Silvestri, Juanita Banuelos, Juanj N Wu, Jude C Dikes, Judy C Nepsa, Julian C Hanson, Ka L Wong, Kaitlyn T Dang, Karen L Bauer, Kari M Johansen, Kassa Ayalew, MD, Katherine E Jacobitz, Kawshalya Pathiraja, Kelvin Cheung, Kelvin X Sanders, Kent A Conforti, Kevin Lee, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Kim Lthomas Cruse, Kimberly M Lichter, Kirsten S Tharp, Kirtida Patel, Kristin M Abaonza, Lakecha N Lewis, Lan T Tran, Lanita F Kelley, Lavender M Huskey, Laverne Kimble, LCDR Wilfred A Darang, Leonard H Lavi, Lester O Boian, Leticia I Romero, Lewisjess, Lilly O Barton, Liming Zhang, Linda Thai, Lisa K Capron, Lori J Silverstein, Loydis Laureano, Lynda L Lanning, Lynette M Terry, Marco A Solorio, Marcus F Yambot, Margo C Jones, Marilyn S Babu, Mariza M Jafary, Mark C Saale, Mark Gray, Matthew C Kristof, Mei Chen Mu, Mendoza O Wallace, Michael D Garcia, Michael J Chan, Michael S Araneta, Michael S Call, Michelle D Haamid, Michelle J Hines, Michelle L Safarik, MSPAS, PA C, RAC, Michelle Safarik, MSPAS, PA C, RAC, Mihaly S Ligmond, Minh D Phan, Msdap Gonzlezk, Nancy Bogdanovic, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Ngoc T Le, Ni Aye Khin, MD, Nianna C Burns, Nicholas J Lahey, Nicholas L Hunt, Norman Wong, Omotunde O Osunsanmi, Paquita F Segarra, Patricia F Alberico, Phal K Chhun, Phillip J Sample, Phillip L Toy, Rabin N Ghoshal, Rafael Padilla, Randy L Elsberry, Raymond W Brullo, Rebecca T Davis, Richard A Abate, Richard M Fejka, Richard W Tubb, Richmond K Yip, Robert C Hoover, Robert D Ogan, Robert S Sweeton, Robert T Lorenz, Rochelle A Rolnik, Rocio Guzman Velazquez, Romero, Ronald L Koller, Ruben G Abrajano, Ruth A Williams, Samson O Oluseye, Sandra L Shire, DMD, MPA, Sara Jdent Acosta, Sarah A Hassas, Scott J Matsuda, Scott K Zika, Sean P Desbrow, Sean P Flood, Selene T Torres, Sherri N Rohlf, MD, Sonia R Peterson, Sonya L Karsik, RAC, Stacey Masters, Stanley Au, Stephanie Mangigian, MS/OSH, RN, Stuart W Russell, Sumit Sen, Sundy V Sedwick, Sunita Vij, Sunitha K Rajaram, PhD, Susan D Yuscius, Susanna N Choi, Sylvia A Thomas, Tanya E Malais, Tara K Carmody, Tara L Stockton, Tawny L Colling, Teena H Aiken, Terrance L Thomas, Thanh B Tran, Thanh M Andrews, Thao T Kwan, Thea C Grome, Theresa Kirkham (NMI), Thomas J Scott, Thomas R Beilke, Trudy R Papson, Truong Xuan Nguyen (Andy), Trushani T Desai, Uttaniti Limchumroon (Tom), Vanessa Y Jacobs, Vashti E Bocker, Vickie L Anderson, Vicky L Cruz, Victor H Loo, Vioela J Caze, Virgilio F Pacio, CSO, Wayne L Jefferson, William D Boden, William J Leonard, William S Vitale, Xavier M Rios, Yangmin Ning, Yen Tso Kuo, Yi Lin, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne T Lacour, Zachary A Bogorad, Zerita White

Angela Shepas's Documents

Publish Date Document Type Title
April, 2015 EIR Ivantis Inc - EIR, 2015-04-09
August, 2016 FDA 483 Endologix Inc - Form 483, 2016-08-18
October, 2015 FDA 483 Applied Medical Resources Corp - Form 483, 2015-10-14
February, 2015 FDA 483 Innovative Ophthalmic Products, Inc - Form 483, 2015-02-12
January, 2014 FDA 483 Joseph S. Gimbel, MD - Form 483, 2014-01-30
August, 2014 FDA 483 Tenacore Holdings, Inc - Form 483, 2014-08-08
July, 2019 FDA 483 James L. Pearle, MD - Form 483, 2019-07-10
March, 2012 FDA 483 Horiba Instruments, Inc dba Horiba Medical - Form 483, 2012-03-01
May, 2019 FDA 483 Puma Biotechnology, Inc. - Form 483, 2019-05-24
March, 2014 EIR Richard C. Keech MD - EIR, 2014-03-20
January, 2018 FDA 483 Prof. Piet P.M.M. Geusens - Form 483, 2018-01-26
October, 2019 FDA 483 Mehrdad Kevin Ariani, MD - Form 483, 2019-10-04
August, 2018 FDA 483 Nexgen Pharma, Inc. - Form 483, 2018-08-17
January, 2013 EIR Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs - EIR, 2013-01-15
August, 2020 FDA 483 BioCorRx Inc - Form 483, 2020-08-14
January, 2019 EIR Allergan Sales, LLC - EIR, 2019-01-22
August, 2019 FDA 483 Rajendra R. Makkar, MD - Form 483, 2019-08-05
May, 2020 FDA 483 Alturas Analytics, Inc. - Form 483, 2020-05-05
March, 2015 FDA 483 Phillips-Medisize Costa Mesa, LLC - Form 483, 2015-03-03
November, 2018 FDA 483 Taddese T. Desta, M.D. - Form 483, 2018-11-07
July, 2012 FDA 483 Malcolm D. Paul, M.D., F.A.C.S., Inc. - Form 483, 2012-07-17
May, 2015 FDA 483 Dr. Tudor-Eliade Ciuleanu - Form 483, 2015-05-01
August, 2018 EIR Nexgen Pharma, Inc. - EIR, 2018-10-04
April, 2018 FDA 483 Peter J. Winkle M.D. - Form 483, 2018-04-20
October, 2019 FDA 483 Herman H. Schroe, MD - Form 483, 2019-10-25
August, 2014 FDA 483 Integrated Orbital Implants Inc. - Form 483, 2014-08-22
April, 2015 FDA 483 Ivantis Inc - Form 483, 2015-04-09
January, 2014 EIR Joseph S. Gimbel, MD - EIR, 2014-01-30
April, 2019 EIR L.A. UNIVERSAL RESEARCH CENTER Inc. - EIR, 2019-04-03
August, 2018 FDA 483 Evagelos Coskinas, MD, PhD - Form 483, 2018-08-31
August, 2016 EIR Endologix Inc - EIR, 2016-08-18
May, 2020 EIR Alturas Analytics, Inc. - EIR, 2020-05-05
February, 2020 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2020-02-21
November, 2014 FDA 483 Silhouette Lift, Inc. - Form 483, 2014-11-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more